Cargando…

The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab

(1) Background: The use of virtual reality (VR) in improving patient comfort related to medical procedures in oncology patients raised the question of whether similar benefits could be obtained by patients with inflammatory bowel disease (IBD). (2) Methods: In this prospective, randomized, controlle...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewandowski, Konrad, Kaniewska, Magdalena, Rosołowski, Mariusz, Kucha, Piotr, Rydzewska, Grażyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235083/
https://www.ncbi.nlm.nih.gov/pubmed/34205323
http://dx.doi.org/10.3390/jcm10122709
_version_ 1783714233749340160
author Lewandowski, Konrad
Kaniewska, Magdalena
Rosołowski, Mariusz
Kucha, Piotr
Rydzewska, Grażyna
author_facet Lewandowski, Konrad
Kaniewska, Magdalena
Rosołowski, Mariusz
Kucha, Piotr
Rydzewska, Grażyna
author_sort Lewandowski, Konrad
collection PubMed
description (1) Background: The use of virtual reality (VR) in improving patient comfort related to medical procedures in oncology patients raised the question of whether similar benefits could be obtained by patients with inflammatory bowel disease (IBD). (2) Methods: In this prospective, randomized, controlled, single-center clinical trial, a total of 90 patients with IBD treated with vedolizumab were enrolled and randomized in a 1:1 allocation to either the VR immersion group or the routine-treated group. The primary outcome was to evaluate whether VR could decrease stress and anxiety related to a medical procedure. The secondary outcome was to assess the safety of the VR. (3) Results: A statistically significant improvement in well-being and psychological comfort (p = 0.046), feeling of relaxation (p = 0.046), sense of influence on the treatment process (p < 0.001), improved perception of the way the drug works (p < 0.001), improved positive attitude while waiting for the next administration of the drug (p = 0.026), and increased motivation for treatment (p = 0.026) was noticed in the intervention group. There were no statistically significant differences in the incidence of complications in the intervention and control groups. (4) Conclusions: The use of VR had a positive effect on the reduction of stress associated with vedolizumab treatment and could improve compliance.
format Online
Article
Text
id pubmed-8235083
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82350832021-06-27 The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab Lewandowski, Konrad Kaniewska, Magdalena Rosołowski, Mariusz Kucha, Piotr Rydzewska, Grażyna J Clin Med Article (1) Background: The use of virtual reality (VR) in improving patient comfort related to medical procedures in oncology patients raised the question of whether similar benefits could be obtained by patients with inflammatory bowel disease (IBD). (2) Methods: In this prospective, randomized, controlled, single-center clinical trial, a total of 90 patients with IBD treated with vedolizumab were enrolled and randomized in a 1:1 allocation to either the VR immersion group or the routine-treated group. The primary outcome was to evaluate whether VR could decrease stress and anxiety related to a medical procedure. The secondary outcome was to assess the safety of the VR. (3) Results: A statistically significant improvement in well-being and psychological comfort (p = 0.046), feeling of relaxation (p = 0.046), sense of influence on the treatment process (p < 0.001), improved perception of the way the drug works (p < 0.001), improved positive attitude while waiting for the next administration of the drug (p = 0.026), and increased motivation for treatment (p = 0.026) was noticed in the intervention group. There were no statistically significant differences in the incidence of complications in the intervention and control groups. (4) Conclusions: The use of VR had a positive effect on the reduction of stress associated with vedolizumab treatment and could improve compliance. MDPI 2021-06-19 /pmc/articles/PMC8235083/ /pubmed/34205323 http://dx.doi.org/10.3390/jcm10122709 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lewandowski, Konrad
Kaniewska, Magdalena
Rosołowski, Mariusz
Kucha, Piotr
Rydzewska, Grażyna
The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
title The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
title_full The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
title_fullStr The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
title_full_unstemmed The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
title_short The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
title_sort use of virtual reality to reduce stress among inflammatory bowel disease patients treated with vedolizumab
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235083/
https://www.ncbi.nlm.nih.gov/pubmed/34205323
http://dx.doi.org/10.3390/jcm10122709
work_keys_str_mv AT lewandowskikonrad theuseofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab
AT kaniewskamagdalena theuseofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab
AT rosołowskimariusz theuseofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab
AT kuchapiotr theuseofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab
AT rydzewskagrazyna theuseofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab
AT lewandowskikonrad useofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab
AT kaniewskamagdalena useofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab
AT rosołowskimariusz useofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab
AT kuchapiotr useofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab
AT rydzewskagrazyna useofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab